Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017

  • ID: 4296627
  • Report
  • 38 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Debiotech SA
  • Eksigent Technologies LLC
  • Eli Lilly and Company
  • Flowonix Medical Inc
  • FluidSynchrony, LLC
  • Intarcia Therapeutics Inc
  • MORE
Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Implantable Infusion Pumps under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry

Reasons to buy

The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Infusion Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Debiotech SA
  • Eksigent Technologies LLC
  • Eli Lilly and Company
  • Flowonix Medical Inc
  • FluidSynchrony, LLC
  • Intarcia Therapeutics Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Implantable Infusion Pumps Overview
3 Products under Development
3.1 Implantable Infusion Pumps - Pipeline Products by Stage of Development
3.2 Implantable Infusion Pumps - Pipeline Products by Territory
3.3 Implantable Infusion Pumps - Pipeline Products by Regulatory Path
3.4 Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
3.5 Implantable Infusion Pumps - Ongoing Clinical Trials
4 Implantable Infusion Pumps - Pipeline Products under Development by Companies
4.1 Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
4.2 Implantable Infusion Pumps - Pipeline Products by Stage of Development
5 Implantable Infusion Pumps Companies and Product Overview
5.1 Alnylam Pharmaceuticals Inc Company Overview
5.1.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Debiotech SA Company Overview
5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Eksigent Technologies LLC Company Overview
5.3.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Eli Lilly and Company Overview
5.4.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
5.5 Flowonix Medical Inc Company Overview
5.5.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 FluidSynchrony, LLC Company Overview
5.6.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Intarcia Therapeutics Inc Company Overview
5.7.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Medallion Therapeutics, Inc. Company Overview
5.8.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Nano Precision Medical Inc Company Overview
5.9.1 Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 University of Minnesota Company Overview
5.10.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.11 University of Southern California Company Overview
5.11.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
6 Implantable Infusion Pumps- Recent Developments
6.1 Mar 14, 2017: Medtronic Announces Class I Recall for SynchroMed II Implantable Drug Infusion Pump
6.2 Mar 14, 2017: Medtronic Announces Class I Recall For SynchroMed EL Implantable Drug Infusion Pumps
6.3 Mar 14, 2017: Flowonix Medical And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy
6.4 Feb 03, 2017: Intarcia Announces FDA Filing Acceptance of New Drug Application for ITCA 650 for the Treatment of Type 2 Diabetes
6.5 Oct 28, 2016: Teleflex Incorporated Signs New Agreement with Premier for Implantable Infusion Ports
6.6 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions
7 Appendix
7.1 Methodology

List of Tables
Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Table 2: Implantable Infusion Pumps - Pipeline Products by Territory
Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
Table 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
Table 5: Implantable Infusion Pumps - Ongoing Clinical Trials
Table 6: Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
Table 7: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Table 8: Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ALN-HTT Infusion System - Product Status
Table 10: ALN-HTT Infusion System - Product Description
Table 11: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: MIP Device - Product Status
Table 13: MIP Device - Product Description
Table 14: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Implantable Drug Delivery System - Product Status
Table 16: Implantable Drug Delivery System - Product Description
Table 17: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Drug Delivery System - Parkinson's Disease - Product Status
Table 19: Drug Delivery System - Parkinson's Disease - Product Description
Table 20: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Implanted Drug Delivery System - Product Status
Table 22: Implanted Drug Delivery System - Product Description
Table 23: Prometra II Programmable Infusion System - Product Status
Table 24: Prometra II Programmable Infusion System - Product Description
Table 25: Flowonix Medical Inc - Ongoing Clinical Trials Overview
Table 26: Prometra II Programmable Infusion System - A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization
Table 27: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 28: FluidSync Pump - Product Status
Table 29: FluidSync Pump - Product Description
Table 30: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ITCA 650 Osmotic Pump - Product Status
Table 32: ITCA 650 Osmotic Pump - Product Description
Table 33: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Medallion Infusion System - Product Status
Table 35: Medallion Infusion System - Product Description
Table 36: Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Nano Portal Capsule - Product Status
Table 38: Nano Portal Capsule - Product Description
Table 39: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Infusion Micropump - Product Status
Table 41: Infusion Micropump - Product Description
Table 42: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Drug Infusion Pump - Product Status
Table 44: Drug Infusion Pump - Product Description
Table 45: Glossary

List of Figures
Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory
Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
Figure 5: Implantable Infusion Pumps - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alnylam Pharmaceuticals Inc
  • Debiotech SA
  • Eksigent Technologies LLC
  • Eli Lilly and Company
  • Flowonix Medical Inc
  • FluidSynchrony, LLC
  • Intarcia Therapeutics Inc
  • Medallion Therapeutics, Inc.
  • Nano Precision Medical Inc
  • University of Minnesota
  • University of Southern California
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll